Get started
Markets India Stocks Health Technology Pharmaceuticals: Major

MARKSANS PHARMA LTD MARKSANS

MARKSANS BSE
MARKSANS
MARKSANS PHARMA LTD BSE
See more on advanced chartSee more on advanced chart
 
No trades
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
See more on advanced chartSee more on advanced chart
Overview
News Ideas Financials Technicals Forecast

MARKSANS chart

Ideas

Pennat BO
MARKSANS
, 1DLong
MARKSANS: Pennat BO

For 10%

Marksans pharma Ready for next 20%
MARKSANS
, 1DLong
MARKSANS: Marksans pharma Ready for next 20%

on close above marked levels . #Themerider #peace_finance

Inverted Head and shoulder breakout likely
MARKSANS
, 1DLong
MARKSANS: Inverted Head and shoulder breakout likely

see the chart

will go up in few days according to wave structure ,,,
MARKSANS
, 60Long
MARKSANS: will go up in few days according to wave structure ,,,

there is a MACD divergence... according to structure it will come down little but it also shoots from this point keep watching but not to forget to use a Stop loss.

Technicals

Analyst rating

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Marksans Pharma Ltd. engages in the research, manufacture, marketing, and sale of pharmaceutical formulations. Its product portfolio spreads over major therapeutic areas such as oncology, gastroenterology, anti-diabetic, cardiovascular, pain management, and gynecology. The company was founded by Mark Bosco Saldanha on April 16, 1992 and is headquartered in Mumbai, India.

News flow

More news